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Abstract 
 
         Introduction  :- The effect of whole body gamma irradiation at 6.5 Gy dose level on 
some biochemical indices and metal levels has been investigated in albino rats.  
         Material  And  Method:-  These  included  the  determination  of  lipid  peroxidation  and 
metallothionein (MT) in liver and kidney. Iron, copper and zinc were measured in liver, kidney 
spleen and intestine. Also the P50 of survival was determined in rats. 
         Results:-  For  the  control  of  these  radiation-induced  disorders,  the  radioprotective 
character of pentoxifylline has been evaluated. Acute γ-radiation-induced disturbances in trace 
metals levels in some organs were studied; specially Fe concentrations which were significantly 
increased  (p≤0.05)  in  liver,  spleen  and  intestine.  Also  γ-radiation-induced  increase  in 
malonaldehyde  (MDA)  levels  as  lipid  peroxidation  indicator  and  decrease  metallothionein 
(MT)-induction as antioxidant defense induced in the cell. Pre-treatment with pentoxifylline was 
not  effective  against  the  changes  produced  by  acute  γ-radiation  on  metals  studied,  lipid 
peroxidation process and MT-induction.  While post treatment showed  positive effect on  liver 
iron and metallothionein levels in liver and kidney.  
         Key words: Pentoxifylline, Radioprotector, Gamma irradiation, Metals.  
 
Introduction
        
         Damage of normal tissue is the most 
important limiting factor in radiotherapy. It 
is possible at least theoretically, to eradicate 
a localized tumor if it is subjected to a large 
dose of  radiation,  but,  practically;  there  is 
always  the  danger  of  damaging  normal 
tissues  adjacent  to  the  tumor.  Recently; 
attempts  have    been  made  to  modify  this 
effect  by  the  administration  of  therapeutic 
agents  after  irradiation  but  before  the 
development  of  the  damage  (Rezvani, 
2003).  One  hypothesis  states  that 
supplementation  with  high  doses  of 
multiple  micronutrients  including  high 
doses  of  antioxidants  (vitamins  C  and  E, 
and carotenoids) may improve the  efficacy 
of  radiation  therapy  by  increasing  tumor 
response and decreasing some of its toxicity 
on normal cells. Another hypothesis, on the 
other  hand,  suggests  that  antioxidants 
(dietary or endogenously made) should  not 
be  used  during  radiation  therapy,  because 
they  would  protect  cancer  cells  against 
 radiation  damage  (Prasad  et  al,  2002). 
There are a number of agents, which have 
been  used  experimentally,  some  clinically, 
to alleviate radiation damage. A number of 
substances,  generally  named  Biological 
Response  Modifiers  (BRMs)  with  diverse 
mode  of  actions  have  been  used  in  post 
irradiation  modification  of  normal  tissue 
reactions  (Rezvani,  2003).  Applications  of 
anticoagulants,  heparin  (Fleming  et  al., 
1962), and dicumarol (Macht and Perlberg, 
1950) as BRMs were the earliest  attempts 
in  the  treatment  of  radiation-induced 
normal  tissues  lesions  (e.g.  pneumonitis), 
however,  they  were  unsuccessful  in 
modifying  the  development  of  radiation 
pneumonitis in the lung. Pentoxifylline has 
shown  significant  beneficial  effect  in  the 
prevention  of  late  radiation  effects  and 
recent evidence  also  suggests that  it  might 
be  beneficial  for  the  treatment  of  acute 
lesions  too  (Rezvani,  2003).  The 
administration  of  pentoxifylline  as  an 
antiinflammatory  may  serve  as  a  novel 
therapeutic adjunct after hemorrhagic chock 
(Deree et al., 2007).  
         The  present  work  was  planned  to 
evaluate  the  biochemical  changes  (lipid 
peroxidation  and  metallothionein  in  liver 
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and  kidney)  as  well  as  the  changes  in  the 
level of some metals in some organs (liver, 
kidney  spleen  and  intestine),  which  might 
occur  in  response  to  whole  body  gamma 
irradiation.  Moreover,  the  effect  of 
administration  of  pentoxifylline,  an 
anticoagulant  for  five  consecutive  days 
before and/or after irradiation on the organs 
metal levels was studied. The survival rate 
of animals was also investigated.  
 
Material And Method 
 
Animals:- 
         Seventy-five  male  albino  rats 
weighing 150-200 g (the Holding Company 
for  Biological  Products  and  Vaccines, 
Vacsera, Cairo, Egypt) were kept in plastic 
cages and were  allowed free  access to  tap 
water and food. 
 
Chemicals:- 
  Nitric  acid  (65%)  (Scharlau)  and 
hydrogen  peroxide  (WINLAB)  for 
tissue digestion. 
  Ferric chloride (Riedel-deHaёn), copper 
metal  (HOPKIN&WILLIAMS),  zinc 
metal  (MERCK)  and  silver  nitrate 
(PROLABO)  for  Atomic  Absorption 
Spectrophotometry  (AAS)  standard 
preparation. 
  Thiobarbituric  acid  (Sigma),  trichlor-
oacetic  acid  (Aldrich)  and  n-butanol 
(Scharlau)  for  lipid  peroxidation 
determination. 
  Silver nitrate, glycine (ADWIC)-NaOH 
(Riedel-deHaёn) buffer,  hemolysate  for 
metallothionein determination. 
 
Drugs:- 
         Torental  (pentoxifylline,  Aventis):  50 
mg /kg body weight given intraperitoneally. 
 
Irradiation:- 
         Animals  were  exposed  to  an  acute 
whole body γ-radiation at 6.5 Gy (dose rate 
0.88381  rad/sec.)  by  using  the  biological 
irradiator  Gamma  cell-40  (caesium-137 
source)  belonging  to  National  Centre  for 
Radiation  Research  and  Technology 
(NCRRT) at Nasr City, Cairo. 
 
Equipments:- 
  UNICAM  939  Atomic  Absorption 
Spectrophotometry (AAS). 
  Milestone  MLS  1200  Mega,  High 
Performance Microwave Digestor Unit. 
  Heλios γ UV/VIS Spectrophotometers. 
 
Experimental design:- 
     42 rats were divided into 7 groups. 
A)  Gp1:  Normal  control  (Saline  treated 
group, n=6):- 
       Each rat was injected intraperitoneally 
by 9% NaCl for five consecutive days. 
 
B) Irradiated group:- 
         12  rats  were  exposed  to  gamma 
irradiation  (6.5  Gy),  then  subdivided 
into two equal groups, 6 rats each: 
      Gp2:  6.5  Gy  gamma  irradiated  rats 
were  scarified  one  day  after  radiation 
exposure. 
      Gp3:  6.5  Gy  gamma  irradiated  rats 
were scarified three days after radiation 
exposure. 
C) Pentoxifylline treated group, n=6:- 
     Gp4: Pentoxifylline control treated:         
      This  group  of  rats  was  treated 
intraperitoneally  with  pentoxifylline 
(50  mg/kg  body  weight)  for  five 
consecutive days. 
 
D) Pretreated irradiated group: 
         12  rats  received  pentoxifylline  daily 
intraperitoneally  (50  mg/kg  body  weight) 
for five consecutive days before irradiation 
(6.5 Gy). The rats were subdivided into two 
equal groups, 6 rats each: 
         Gp5: 6 pretreated rats were scarified 
one day after radiation exposure. 
         Gp6: 6 pretreated rats were scarified 
three days after radiation exposure. 
 
E) Post-treated irradiated group: 
         Gp7:  6  rats  received  pentoxifylline 
daily  intraperitoneally  (50  mg/kg  body 
weight)  for  five  consecutive  days  after 
irradiation  (6.5Gy),  they  then  were 
scarified. 
-  Radioprotective  effect  of  pentoxifylline 
against mortality: 
         A group of normal rats (n=16) and a 
group  of  rats  (n=16)  pretreated  with 
pentoxifylline  (50  mg/kg  body  weight  i.p.) 
for five consecutive days were subjected to 
gamma  irradiation  (6.5  Gy)  given  as  a 
single  dose.  The  number  of  rats  surviving 
28  days  after  irradiation  was  counted  and 
the mortality rate was calculated.  Esmat A. Shaban & Asrar M. Hawas 
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Sample collection:- 
         Samples were collected 1 and 3 days 
after irradiation exposure and 5 days after 
pentoxifylline  treatment.  Animals  were 
anesthetized  with  diethyl  ether.  Tissues 
(liver,  kidney,  spleen  and  intestine)  were 
separated  and  washed  by  deionized  water 
for  metal  analysis  and  biochemical 
determinations  (lipid  peroxidation  and 
metallothionein in liver and kidney).  
 
Lipid peroxidation determination:- 
         Lipid peroxidation levels were ascert-
ained  by  the  formation  of  malonaldehyde 
(MDA).  Sample  preparation  for  lipid 
peroxidation was performed as described by 
Sander et al. (1996). 0.5 ml of homogenate 
was  treated  for  determination  of  lipid 
peroxidation  as  described  by  Yoshioka  et 
al. (1979). 
 
Metallothionein determination:- 
         Metallothionein  levels  were  deter-
mined by Ag-saturation hemolysate method 
according  to  Scheuhammer  and  Cherian 
(1986) and Bienengräber et al. (1995). 
 
Trace metals analysis:- 
         Iron, copper and zinc were measured 
in  the  liver,  kidney,  spleen  and  intestine. 
The organs were weighed and put in special 
vessels  with  6  ml  nitric  acid  and  1  ml 
hydrogen  peroxide  for  the  digestion 
process.  Samples  were  diluted  to  suitable 
levels for metals analysis by AAS.  
 
Statistical analysis:- 
         Student`s t-test was used for statistical 
analysis  of  results  (Kirkwood,  1988).  A  p 
value ≤0.05 was considered significant. 
 
Results 
 
Survival rate:- 
         The  results  obtained  are  graphically 
presented  in  Fig.  (1).  Being  a  sublethal 
radiation  dose  (6.5  Gy),  almost  all  the 
irradiated control rats have died during the 
post-exposure period of 18 days. The P50 of 
survival was 8 days in irradiated rats, and 
was  significantly  increased  to  20  days  in 
irradiated  rats  which  received  pentoxif-
ylline for 5 days prior to gamma irradiation 
(Fig. 1). 
 
Effect of irradiation and pentoxifylline on 
metal content compared to normal control 
(non irradiated control) (Tab.1, Fig.2):- 
A)  Our  results  showed  significant 
difference  (p≤0.05)  between  both 
control  groups  (non  irradiated  control 
and pentoxifylline control treated rats); 
where  pentoxifylline  caused  significant 
decrease  in  Cu  liver  level.  In  kidney, 
there was significant decrease in Fe and 
significant  increase  in  Cu  level.  In 
spleen  and  intestine  there  were 
significant decrease in  Fe and Cu  also 
showed  significant  decrease  in  the 
intestine. 
B) One day after irradiation (Tab.1, Fig.2): 
     Liver showed  significant  increase  in  Fe 
level in irradiated group and significant 
decrease in Cu and Zn levels. Kidney of 
irradiated  rats  showed  significant 
decrease  in  Fe  and  Zn  levels  and 
significant  increase  in  Cu  level 
(p≤0.05).  However,  the  spleen  and 
intestine showed significant increase  in 
Fe, Cu and Zn levels in the 1
st day after 
irradiation (p≤0.05).   
C)  Three  days  after  irradiation  (Tab.1, 
Fig.2):  Liver  iron  concentration  was 
significantly increased while Cu and Zn 
concentrations  significantly  decreased 
(p≤0.05).  In  this  group,  there  was 
significant  increase  in  kidney  Fe  and 
Cu and significant decrease in Zn levels 
(p≤0.05).  Spleen  metals  (Fe,  Cu  and 
Zn)  concentrations  showed  significant 
increase  in  the  3
rd  day  of  irradiation. 
The  intestine  showed  significant 
increase in Fe. 
         Effect  of  irradiation  and  pentoxif-
ylline on MDA (lipid peroxidation marker) 
and  MT  (metallothionein)  levels  compared 
to  normal  control  (non  irradiated  control) 
(Tab.2, Fig.3):- 
         There  was  no  significant  difference 
(p≤0.05)  in  MDA  levels  between  both 
control  groups  while  significant  decrease 
occurred in MT levels. MDA levels showed 
significant  increase  in  liver  at  1
st  and  3
rd 
days after irradiation. In kidney, there was 
significant increase  in MDA  one day  after 
irradiation.  
         Liver  and  kidney  MT  levels  showed 
significant  decrease  in  irradiated  and 
pentoxifylline-treated groups. Pentoxifylline As A Radioprotector Against Certain…………. 
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-  Effect  of  pentoxifylline  pre-treatment 
and  post-treatment  on  metal  content 
compared  with  irradiated  group  (Tab.  1, 
Fig. 2):- 
A)  1
st  day  pretreated  irradiation  compared 
with 1
st day irradiation (Tab. 1, Fig. 2): 
      Liver,  spleen  and  intestine  showed 
significant  decrease  in  Fe  levels  and 
significant  increase  in  Cu  and  Zn 
levels, except of intestine which had no 
significant  increase  in  Cu.  In  kidney, 
there  was  significant  increase  in  all 
metals (Fe, Cu and Zn). 
 
B)  3
rd  day  pretreated  irradiated  group 
compared with 3
rd day irradiated group 
(Tab. 1, Fig. 2): 
     In liver, no significant change in Fe level 
but there was significant increase in Cu 
and  Zn  levels.  Kidney  and  spleen 
exhibited  significant  increase  in  all 
metals (Fe, Cu and Zn) while intestine 
showed  significant  decrease  in  all 
metals studied (Fe, Cu and Zn). 
 
C)  Post-treated  irradiated  group  compared 
with  1
st  day  irradiated  group  (Tab.  1, 
Fig. 2): 
         There  was  significant  decrease  in  all 
metals (Fe, Cu and Zn) in liver, kidney and 
intestine with except of liver Cu and kidney 
Fe which showed no significant effect. The 
spleen  showed  significant  increase  in  Fe 
and Cu and no significant effect in Zn.  
 
-  Effect  of  pentoxifylline  pre-treated  and 
post-treated groups on MDA and MT levels 
compared  with    irradiated  group  (Tab.2, 
Fig.3):- 
         After 1 day  of irradiation, there  was 
non significant effect on MDA in liver and 
kidney but there was significant decrease in 
MT  levels.  3
rd  day  of  irradiation  showed 
significant increase in MDA levels in both 
organs.  In  liver,  there  was  significant 
increase  in  MT  level  and  significant 
decrease  in  kidney  MT  level.  Post-treated 
irradiated  group  showed  significant 
decrease  in  kidney  MDA  level  and 
significant  increase  in  MT  levels  in  liver 
and kidney. 
  Esmat A. Shaban & Asrar M. Hawas 
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Table (1): Concentration of metals (Fe, Cu and Zn) (µg/g wet  weight , mean ± SE) in liver, 
kidney, spleen and intestine in male rats (n=6) exposed to γ- radiation (6.5 Gy) 
and/or treated with pentoxifylline (50 mg /kg body weight for five consecutive 
days) prior and post irradiation exposure (mean ± SE). 
   
 * Significantly different from mon irradiated control at p≤0.05.   
 ** Significantly different from irradiated group at p≤0.05.  
   
Table (2): Concentration of MDA (nmol/g wet weight) and MT (µg/g wet weight) (mean ± 
SE)  in  liver  and  kidney  in  male  rats  (n=6)  exposed  to  γ-  radiation  (6.5  Gy) 
and/or treated  with  pentoxifylline  (50  mg  /kg  body  weight  for  five  consecutive 
days) prior and post irradiation exposure (mean ± SE).  
  
       Groups 
Organs  
Non 
irradiated 
control 
Irradiation only 
      1
st day                   3
rd day 
Pentoxifylline 
Control 
treated 
Pretreated irradiation  
      1
st day                   3
rd day 
Post-treated 
irradiation  
Liver   MDA 
              MT 
82.36 ± 2.522 
995.2 ± 37.53 
105.9 ± 1.222* 
727.2 ± 34.08* 
97.19 ± 2.135* 
283.9 ± 7.267* 
86.53 ± 2.648 
614.4 ± 23.38* 
107.3±1.475 
422.7±10.86** 
176.1±2.206** 
417.2±7.669** 
110.6±5.377 
823.0±31.68** 
Kidney  MDA 
              MT 
121.1 ± 1.316 
988.3 ± 35.12 
133.8 ± 1.654* 
675.6 ± 20.76* 
123.4 ± 1.603 
596.7 ± 16.80* 
119.2 ± 4.204 
699.5 ± 12.57* 
136.4±2.722 
604.0±15.38** 
208.6±4.343** 
553.9±14.74** 
127.8±2.360** 
961.8±45.14** 
            * Significantly different from mon irradiated control at p≤0.05.   
          ** Significantly different from irradiated group at p≤0.05.  
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Fig. (1):  Survival  rate  of  irradiated  rats  (P50=8)  compared  to  pretreated  irradiated  rats 
(P50=20) 
          Groups 
Organs  
Non 
irradiated 
control 
Irradiation only 
      1
st day                   3
rd day 
Pentoxifylline 
control treated 
Pretreated irradiation  
      1
st day                   3
rd day 
Post-treated 
irradiation  
Liver         Fe 
                 Cu 
                  Zn 
183.7 ± 3.519 
3.150 ± 0.111 
33.18 ± 1.215 
228.3 ± 9.924* 
2.382 ± 0.077* 
24.99 ± 0.821* 
230.1 ± 6.087* 
2.841 ± 0.096* 
26.72 ± 0.978* 
180.7 ± 3.858 
2.465 ± 0.039* 
30.92 ± 1.445 
144.5±3.890** 
2.865±0.048** 
29.58±0.774** 
232.0±3.835 
3.498±0.088** 
32.70±0.817** 
183.0±3.666** 
2.229±0.082 
22.56±0.728** 
Kidney      Fe 
                 Cu 
                  Zn 
121.9 ± 2.425 
3.645 ± 0.081 
34.11 ± 1.094 
110.0 ± 1.642* 
3.981 ± 0.077* 
29.28 ± 0.904* 
131.0 ± 3.017* 
4.087 ± 0.134* 
29.61 ± 0.986* 
110.4 ± 1.942* 
3.910 ± 0.111* 
32.04 ± 0.849 
162.8±3.923** 
4.785±0.165** 
39.44±0.370** 
151.8±3.086** 
4.829±0.129** 
38.48±1.358** 
105.9±2.208 
3.304±0.139** 
26.70±0.944** 
Spleen       Fe 
                 Cu 
                  Zn 
1003 ± 39.02 
1.280 ± 0.060 
30.55 ± 1.171 
1385 ± 64.23* 
1.444 ± 0.035* 
38.07 ± 1.272* 
1300 ± 29.73* 
1.843 ± 0.057* 
40.22 ± 0.670* 
784.9 ± 36.91* 
1.289 ± 0.060 
33.29 ± 1.146 
1157±51.45** 
2.806±0.027** 
61.54±1.344** 
1861±99.54** 
2.779±0.123** 
71.42±2.216** 
2091±105.4** 
1.990±0.053** 
40.95±1.626 
Intestine   Fe 
               Cu 
                Zn 
31.21 ± 1.048 
1.451 ± 0.033 
32.65 ± 1.356 
42.56 ± 1.714* 
1.603 ± 0.049* 
38.81 ± 0.899* 
42.10 ± 1.544* 
1.467 ± 0.064 
35.62 ± 0.985 
25.68 ± 1.380* 
1.325 ± 0.040* 
29.18 ± 1.402 
39.83±1.373** 
1.668±0.066 
42.53±0.693** 
35.14±0.813** 
1.305±0.028** 
32.86±0.922** 
29.27±0.993** 
 1.175±0.031** 
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* Significant difference at p≤0.05 as compared to normal control(Gp 1).  
** Significant difference at p≤0.05 as compared to iradiated control.    
N.B.: 1
st day pre-treated irradiated group (Gp 5) compared to 1
st day irradiated group (Gp 2). 
        3
rd day pre-treated irradiated group (Gp 6) compared to 3
rd day irradiated group (Gp 3). 
        Post-treated irradiated group (Gp 7) compared to 1
st day irradiated group (Gp 2).                                                                     
 
 
Fig. (2a): Concentration of metals (ug/g wet 
weight,  mean  ±  SE)  in  rats  (n=6)  liver 
exposed  to  γ-radiation  (6.5  Gy)  and/or 
pentoxifylline  (50  mg/kg  body  weight  for 
five consecutive days). 
 
Fig. (2b): Concentration of metals (ug/g wet  
weight,  mean  ±  SE)  in  rats  (n=6)  kidney 
exposed  to  γ-radiation  (6.5  Gy)  and/or 
pentoxifylline  (50  mg/kg  body  weight  for 
five consecutive days). Esmat A. Shaban & Asrar M. Hawas 
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* Significance difference at p≤0.05 as compared to normal control(Gp 1).   
** Significance difference at p≤0.05 as compared to irradiated control.    
N.B.: 1
st day pre-treated irradiated group (Gp 5) compared to 1
st day irradiated group (Gp 2). 
        3
rd day pre-treated irradiated group (Gp 6) compared to 3
rd day irradiated group (Gp 3). 
        Post-treated irradiated group (Gp 7) compared to 1
st day irradiated group (Gp 2).                                                                     
 
 
Fig. (2c): Concentration of metals (ug/g wet 
weight,  mean  ±  SE)  in  rats  (n=6)  spleen 
exposed  to  γ-radiation  (6.5  Gy)  and/or 
pentoxifylline  (50  mg/kg  body  weight  for  five 
consecutive days). 
 
Fig. (2d): Concentration of metals (ug/g wet 
weight,  mean  ±  SE)  in  rats  (n=6)  intestine 
exposed  to  γ-radiation  (6.5  Gy)  and/or 
pentoxifylline  (50  mg/kg  body  weight  for  five 
consecutive days). 
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Fig. (3): MDA and MT levels (mean ± SE) in rats (n=6) liver and kidney exposed to γ-radiation 
(6.5 Gy) and/or pentoxifylline (50 mg /kg body weight for five consecutive days). 
* Significance difference at p≤0.05 as compared to normal control(Gp 1).   
** Significance difference at p≤0.05 as compared to irradiated control.    
N.B.: 1
st day pre-treated irradiated group (Gp 5) compared to 1
st day irradiated group (Gp 2). 
        3
rd day pre-treated irradiated group (Gp 6) compared to 3
rd day irradiated group (Gp 3). 
        Post-treated irradiated group (Gp 7) compared to 1
st day irradiated group (Gp 2).                                                                     
 
 
Discussion 
     
         In  the  present  work,  we  investigated 
the  effect  of  γ-radiation  and/or 
pentoxifylline  on  certain  trace  metals 
concentration  (Fe,  Cu  and  Zn),  these 
metalloelements are required by all cells for 
normal  metabolic  processes  (Tipton  and 
Cook,  1963).  Trace  elements  play  a  very 
important role in many biological activities; 
their imbalance may be a contributor to, or 
a  result  of  organ  dysfunction  (Elnimr  and 
Abdel-Rahim,  1998).  It  is  recognized  that 
loss  of  enzymes  activity  dependent  on 
essential  metalloelements  may  at  least 
partially  account  for  lethality  of  ionizing 
radiation  and  that  Fe-,  Cu-,  Mn-  and  Zn- 
dependent enzymes have roles in protecting 
against  accumulation  of  O
˙
2  as  well  as  in 
facilitating repair (Gelman et al, 1978).  
         The  liver  histopathological  changes 
seen  post-irradiation,  include  occlusion  of 
the  small  hepatic  veins  leading  to  sinus 
congestion,  hyperemia  and  hemorrhage 
(Edward, 1990) which may explain the Fe 
increasing in liver at 1
st and 3
rd days after 
irradiation (Tab.1, Fig.2a) and the excess of 
iron presented to the kidney (at 3
rd day after 
irradiation, Tab.1, Fig.2b) for excretion and 
conversion  to  ferritin  (Hampton  and 
Mayerson, 1950). 
         Irradiated  group  showed  significant 
increase  in  spleen  iron  levels  (Tab.1, 
Fig.2c) one and three days after irradiation Esmat A. Shaban & Asrar M. Hawas 
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compared  with  control  Kotb  et  al.  (1990) 
reported  that  accumulation  of  iron  in  the 
spleen  may  result  from  disturbance  in  the 
biological  function  of  red  blood  cells, 
including  possible  intravascular  hemolysis 
and  subsequent  storage  of  iron  in  the 
spleen.  At  the  1
st  day  in  pretreated 
irradiated  group,  Fe  levels  decreased  in 
liver,  spleen  and  intestine  (Tab.1, 
Fig.2a,c,d) compared with irradiated group 
and  in  post-treated  irradiated  group,  Fe 
levels  decreased  in  liver  and  intestine 
(Tab.1, Fig.2a,d). It is known that the basic 
action of pentoxifylline is increasing of red 
blood  cells  flexibility,  reduction  of  blood 
viscosity  and  decrease  potential  of  platelet 
aggregation  (Okunieff  et  al,  2004; 
Windmeier and Gressner, 1997) which may 
ameliorate  the  deleterious  effect  of 
radiation.  After  the  3
rd  day  of  irradiation, 
the kidney  exhibited significant  increase  in 
Fe and Cu levels (Tab.1, Fig.2b). Cengiz et 
al. (2003)  concluded  that  a  sublethal  dose 
of  total  body  irradiation  causes  deposition 
of  Cu  and  Fe  within  the  kidney  8  weeks 
after  irradiation.  Deposition  of  these 
elements may have some additional role of 
the  toxicity  caused  by  direct  radiation  on 
the  kidney.  Yarmonenko  (1988)  mentioned 
that  the  effect  of  radiation  on 
gastrointestinal tract includes baring of the 
villi, infection, damage to the blood vessels 
and disturbance of the balance of liquid and 
electrolytes.  Gregus  and  Klaassen  (1986) 
reported that fecal excretion of metals may 
originate  from  hepatobiliary  transport. 
There  was  significant  increase  in  the 
intestine Zn level at 1
st day after irradiation 
compared with control and at the 1
st day of 
pretreated  irradiated  group  compared  with 
1
st day of irradiated group (Tab.1, Fig.2d). 
Solomons  and  Cousins  (1984)  noted  that 
substantial  amount  of  zinc  is  excreted  by 
the  pancreas  and  secreted  by  the  small 
intestine.  
     The increasing of the oxidative stress via 
radiation  exposure  effects  inhibit  the 
antioxidant  defense  system  (Carrier  et  al, 
2002),  and  induce  oxidative  modifications 
of the membranes, thus, increase fragility of 
red blood cells ( wagner et al, 1988; Stern, 
1986).  Increasing  of  MDA  (as  lipid 
peroxidation  indicator)  levels  in  liver  and 
kidney  (Tab.2,  Fig.3a,b)  refer  to  the 
damage  effect  of  radiation  as  free  radical 
inducing factor (Sun et al, 1995). The pre- 
and  post-treatment  by  pentoxifylline  (50 
mg/kg  body  weight  for  five  consecutive 
days) as radioprotector drug for this acute 
dose  of  radiation  (6.5  Gy)  cannot  prevent 
the  damage  effect  of  radiation. 
Metallothionein  levels  in  liver  and  kidney 
(Tab.2, Fig.3a,b) was affected by radiation, 
where  significant  decrease  occurred  in  all 
groups with exception of post-treated group 
with  pentoxifylline  while  metallothionein 
level  started  to  elevate  but  not  restored 
completely  to  the  control  levels  especially 
in liver.   
         It  is  known  that  pentoxifylline  has  a 
radio-protective effect which can prevent or 
ameliorate  late  radiation  injury  in  animals 
and humans (Stelzer et al, 1994). The most 
important  pentoxifylline  mechanism  for 
altering radiation damage may be its ability 
to  increase  locoregional  blood  flow. 
Pentoxifylline  improves  blood  flow  by  a 
multi-tiered  process.  Firstly  it  inhibits 
cAMP  phosphodiesterase  and  thereby 
increases cAMP (Windmeier and Gressner, 
1997)  and  ATP  in  RBCs,  improving  their 
deformability.  Pentoxifylline  also  can 
promote  streamlined  blood  flow  by 
inhibiting  intercellular  adhesion  molecule 
(ICAM)  expression,  minimizing  leukocyte 
adherence  to  endothelial  cells,  and  increa-
sing  prostacycline  production,  thus, 
inhibiting  platelet  aggregation.  By  increa-
sing  prostacycline  levels  and  decreasing 
thromboxane  effect,  pentoxifylline  dilates 
capillaries.  Finally,  it  decreases  plasma 
fibrinogen  concentrations  and  increases 
fibrinolytic  activity.  Each  of  these  effects 
alone  could  improve  vascular  blood  flow. 
In  concert,  these  effects  decrease  both 
whole  blood  viscosity,  and  systemic 
vascular resistance. The alleviation of tissue 
hypoxia  in  turn  may  reduce  angiogenic 
stimuli  and  thus  could  account  for  the 
reduced Fibroplast  Growth Factor  2  levels 
(FGF2) (Okunieff et al, 2004). Also Maiti 
et al. (2007) study revealed improvement in 
inflammatory markers, oxidative stress and 
platelet aggregation by pentoxifylline.              
         In the present study, pre-treatment by 
pentoxifylline  (50  mg/kg  body  weight  for 
five  consecutive  days)  was  not  effective 
against  the  damaging  effects  of  acute 
radiation (dose 6.5 Gy) on metals (Fe, Cu 
and  Zn)  in  liver,  kidney,  spleen  and Pentoxifylline As A Radioprotector Against Certain…………. 
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intestine, also on lipid peroxidation process 
and  metallothionein  induction  in  liver  and 
kidney.  While  post  treatment  showed 
positive  effect  on  liver  iron  and 
metallothionein levels in liver and kidney. 
         According to Misirliogu et al. (2007), 
the  combined  use  of  pentoxifylline  and 
vitamin  E  is  reported  to  reduce  radiation-
induced  toxicity  on  normal  tissues  at 
molecular levels.  
         Increasing  experimental  and  clinical 
evidence  suggests  the  efficacy  of 
pentoxifylline  in  the  treatment  of  radiation 
injury;  particularly  late  effect.  Thus 
pentoxifylline,  particularly  combined  with 
α-tocopherol  (vitamin  E)  may  act  as  an 
effective  Biological  Response  Modifier 
(BRM).  Also  long  term  administration  of 
pentoxifylline  in  animal  prior  to  radiation 
exposure  may  prevent  the  deleterious 
damage  effect  of  acute  γ-radiation 
exposure.                   
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 ىف سيغحلاو ةيويحوميكلا للاحخلإا دض هيليفيسكوحنبلا ءاودل ىئبقولا زودلا
ىمبجلا عيعشحلل ةضسعملا ناذسجلا ىف ندبعملا تبيوحسم  
 
ساوح داسم دمحم زاسسأ ،نببعش ملاسلا دبع ثمصع  
 عبعشلإا بيجولونكجو خوحبل ىموقلا زكسملا -   ةيزرلا ةقبطلا ةئيه  
 
      
            ج تممش   رممه ازدلا   ثهدمملا  ثخمم ا ومملا تممسثملثتمةلا ثاسممماخلا يمملا ضمممميح تممس
 وملا ت م مللا سمياشللا يملا سسدميح ا لم ةلاا دموةلا لمف فمنثموثلامخمتلاا دم كأخلا تيئاف
 لمف  المش ا فملإ تمعحاشلاا ااملاعاا وام حلا ،لم ةلا ،دوةلا لف كنصلاا ضا شلا ،دسد لا
 تملإالشإ تلإسعا لااعلا عمللخ ل تضسلتلا  اذسعلا 5.6    اسج  .  ضة خلا تمفمك تسازدلا
 فما ل اثمك فم  مفمم كثخشولا اااب سموأمح ضممميح ضمح  المش ا فملإ تمعحاشلا ثاااسحمض ا لف
ضسلخلا دلاا وو   الش ا  .  
       لمممف ت م مممللا سمممياشللا ثاسثخممم ا لمممف ثاااسحمممضإ لممملإ  بى  المممشال ضسممملخلا
  ا ةباسصا عفحزإ  رلاا دسد لا تياخ اهخسازب ضح لخلا ااضلإعا  وا حلا ،دوةلا لف هظث
االاعاا  .  دمساهسدلانثلاتلا ثاسثخم ا لف هظث  ا ةباسش للإ  الشال ضسلخلا  بى آضسى
MDA    فمنثموثلامخمتلا فمحاسما بامخنإ لمف صينا  ثهدلا ةد كى تم تلإ ل لإ وملدلا MT  
تم خلا وخاب ةد كلأل باضتك  .  فما ةبامل تملإسعل ضسملخلا ومو  فم  مفمم كثخشولا مادخخسإ
 الش ا    لمف وم خلا بجملإ لف لآالف فةس ضل ثاسثخم ا   ت م مللا سمياشللا  تمم تلإ لمف اى ،
 ثهدمملا ةدمم كى   ا فمنثموثلاممخمتلا فمحاسمما باممخنإ  .  دمملا بجمملك هاادخخممسإ اممتشما  ضسمملخلا
ل  المشا    لمف آممااعسإ إسموأمح سمهظى ثاسثخمم ا   ا دموةلا لمف دمسد لا فمنثموثلامخمتلا    دمموةلا لمف
ل ةلاا  .  اثض لف جئاخشلا تل اشا ضحا تلسد لا تمت للا عجاستلا  .  
 
 
 
 